Catalio Capital Management »

Eli Lilly & Co. shares owned by Catalio Capital Management

Quarter-by-quarter ownership of Eli Lilly & Co. (LLY) shares owned by Catalio Capital Management from 13F filings

Historical chart of Catalio Capital Management investment in Eli Lilly & Co.

Tip: Access up to 7 years of quarterly data

All positions including Eli Lilly & Co. held by Catalio Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eli Lilly & Co. by Catalio Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $44M 57k 763.00

More positions owned by Catalio Capital Management

Eli Lilly & Co. (LLY)
Abbvie (ABBV)
Bridgebio Pharma (BBIO)
Intuitive Surgical Com New (ISRG)
Ascendis Pharma A/s Sponsored Adr (ASND)
Soleno Therapeutics (SLNO)
Dianthus Therapeutics (DNTH)
Boston Scientific Corporation (BSX)
Syndax Pharmaceuticals (SNDX)
Cytokinetics Com New (CYTK)
Natera (NTRA)
Regeneron Pharmaceuticals (REGN)
Structure Therapeutics Sponsored Ads (GPCR)
Uniqure Nv SHS (QURE)
Disc Medicine (IRON)

View all positions for Catalio Capital Management

Top funds holding Eli Lilly & Co.

Lilly Endowment
Vanguard Group
BlackRock
Pnc Financial Services
State Street Corporation
Capital Research Global Investors
FMR
Geode Capital Management
Capital World Investors
Wellington Management Company
State Farm Mutual Automobile Insurance Company
PRIMECAP Management Company
Jpmorgan Chase & Co
Capital Research and Management Company - Division 3
Northern Trust

View all funds holding Eli Lilly & Co.